HEADER SUGAR BINDING PROTEIN 18-NOV-11 3VKM TITLE PROTEASE-RESISTANT MUTANT FORM OF HUMAN GALECTIN-8 IN COMPLEX WITH TITLE 2 SIALYLLACTOSE AND LACTOSE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GALECTIN-8; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N-TERMINAL CARBOHYDRATE RECOGNITION DOMAIN, C-TERMINAL COMPND 5 CARBOHYDRATE RECOGNITION DOMAIN; COMPND 6 SYNONYM: GAL-8, PO66 CARBOHYDRATE-BINDING PROTEIN, PO66-CBP, PROSTATE COMPND 7 CARCINOMA TUMOR ANTIGEN 1, PCTA-1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LGALS8; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BETA-SANDWICH, CARBOHYDRATE BINDING, OLIGOSACCHARIDE, SUGAR BINDING KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR H.YOSHIDA,S.YAMASHITA,M.TERAOKA,S.NAKAKITA,N.NISHI,S.KAMITORI REVDAT 5 08-NOV-23 3VKM 1 HETSYN REVDAT 4 29-JUL-20 3VKM 1 COMPND REMARK SEQADV HETNAM REVDAT 4 2 1 LINK SITE ATOM REVDAT 3 16-AUG-17 3VKM 1 SOURCE REMARK REVDAT 2 03-JUL-13 3VKM 1 JRNL REVDAT 1 12-SEP-12 3VKM 0 JRNL AUTH H.YOSHIDA,S.YAMASHITA,M.TERAOKA,A.ITOH,S.NAKAKITA,N.NISHI, JRNL AUTH 2 S.KAMITORI JRNL TITL X-RAY STRUCTURE OF A PROTEASE-RESISTANT MUTANT FORM OF HUMAN JRNL TITL 2 GALECTIN-8 WITH TWO CARBOHYDRATE RECOGNITION DOMAINS JRNL REF FEBS J. V. 279 3937 2012 JRNL REFN ISSN 1742-464X JRNL PMID 22913484 JRNL DOI 10.1111/J.1742-4658.2012.08753.X REMARK 2 REMARK 2 RESOLUTION. 2.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 93295.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.7 REMARK 3 NUMBER OF REFLECTIONS : 15561 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1576 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.98 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.17 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2094 REMARK 3 BIN R VALUE (WORKING SET) : 0.3010 REMARK 3 BIN FREE R VALUE : 0.3890 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 239 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.025 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4664 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 228 REMARK 3 SOLVENT ATOMS : 146 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 1.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.65 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 17.86000 REMARK 3 B22 (A**2) : 8.22000 REMARK 3 B33 (A**2) : -26.08000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.42 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.58 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.870 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 23.23 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : WATER.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3VKM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-NOV-11. REMARK 100 THE DEPOSITION ID IS D_1000095162. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-NOV-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : AR-NW12A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16883 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.980 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.08700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.49700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2YV8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2-3%(V/V) 1,4-DIOXANE, 9-10%(W/V) REMARK 280 PEG20000, 0.1M BICINE, PH 9.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.06650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.64800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.35650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.64800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.06650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.35650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHOR STATES THAT THE BIOLOGICAL ASSEMBLY IS MONOMER OR REMARK 300 PSEUDO-DIMER OR UNKNOWN. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU A 100 O HOH A 562 3544 1.83 REMARK 500 O HOH A 511 O HOH A 562 3544 1.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 2 95.01 -174.14 REMARK 500 ASN A 7 36.62 -146.09 REMARK 500 ALA A 43 117.25 -9.80 REMARK 500 ALA A 73 -78.21 -67.83 REMARK 500 ASP A 94 40.45 70.63 REMARK 500 PHE A 153 -152.09 -116.30 REMARK 500 HIS A 156 -16.90 -46.92 REMARK 500 ASN A 192 2.25 -59.10 REMARK 500 LYS A 222 -88.14 -42.41 REMARK 500 SER A 223 8.46 -60.76 REMARK 500 SER A 258 122.79 179.05 REMARK 500 LEU B 8 36.56 -96.22 REMARK 500 LYS B 57 105.98 -163.11 REMARK 500 ALA B 73 -89.58 -70.89 REMARK 500 MET B 157 65.61 -157.17 REMARK 500 ARG B 184 154.10 -48.23 REMARK 500 SER B 258 126.06 -175.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4FQZ RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH A DIFFERENT CRYSTAL FORM REMARK 900 RELATED ID: 3VKL RELATED DB: PDB REMARK 900 RELATED ID: 3VKN RELATED DB: PDB REMARK 900 RELATED ID: 3VKO RELATED DB: PDB DBREF 3VKM A 1 155 UNP O00214 LEG8_HUMAN 1 155 DBREF 3VKM A 184 317 UNP O00214 LEG8_HUMAN 184 317 DBREF 3VKM B 1 155 UNP O00214 LEG8_HUMAN 1 155 DBREF 3VKM B 184 317 UNP O00214 LEG8_HUMAN 184 317 SEQADV 3VKM HIS A 156 UNP O00214 LINKER SEQADV 3VKM MET A 157 UNP O00214 LINKER SEQADV 3VKM HIS B 156 UNP O00214 LINKER SEQADV 3VKM MET B 157 UNP O00214 LINKER SEQRES 1 A 291 MET MET LEU SER LEU ASN ASN LEU GLN ASN ILE ILE TYR SEQRES 2 A 291 ASN PRO VAL ILE PRO PHE VAL GLY THR ILE PRO ASP GLN SEQRES 3 A 291 LEU ASP PRO GLY THR LEU ILE VAL ILE ARG GLY HIS VAL SEQRES 4 A 291 PRO SER ASP ALA ASP ARG PHE GLN VAL ASP LEU GLN ASN SEQRES 5 A 291 GLY SER SER MET LYS PRO ARG ALA ASP VAL ALA PHE HIS SEQRES 6 A 291 PHE ASN PRO ARG PHE LYS ARG ALA GLY CYS ILE VAL CYS SEQRES 7 A 291 ASN THR LEU ILE ASN GLU LYS TRP GLY ARG GLU GLU ILE SEQRES 8 A 291 THR TYR ASP THR PRO PHE LYS ARG GLU LYS SER PHE GLU SEQRES 9 A 291 ILE VAL ILE MET VAL LEU LYS ASP LYS PHE GLN VAL ALA SEQRES 10 A 291 VAL ASN GLY LYS HIS THR LEU LEU TYR GLY HIS ARG ILE SEQRES 11 A 291 GLY PRO GLU LYS ILE ASP THR LEU GLY ILE TYR GLY LYS SEQRES 12 A 291 VAL ASN ILE HIS SER ILE GLY PHE SER PHE SER SER HIS SEQRES 13 A 291 MET ARG LEU PRO PHE ALA ALA ARG LEU ASN THR PRO MET SEQRES 14 A 291 GLY PRO GLY ARG THR VAL VAL VAL LYS GLY GLU VAL ASN SEQRES 15 A 291 ALA ASN ALA LYS SER PHE ASN VAL ASP LEU LEU ALA GLY SEQRES 16 A 291 LYS SER LYS ASP ILE ALA LEU HIS LEU ASN PRO ARG LEU SEQRES 17 A 291 ASN ILE LYS ALA PHE VAL ARG ASN SER PHE LEU GLN GLU SEQRES 18 A 291 SER TRP GLY GLU GLU GLU ARG ASN ILE THR SER PHE PRO SEQRES 19 A 291 PHE SER PRO GLY MET TYR PHE GLU MET ILE ILE TYR CYS SEQRES 20 A 291 ASP VAL ARG GLU PHE LYS VAL ALA VAL ASN GLY VAL HIS SEQRES 21 A 291 SER LEU GLU TYR LYS HIS ARG PHE LYS GLU LEU SER SER SEQRES 22 A 291 ILE ASP THR LEU GLU ILE ASN GLY ASP ILE HIS LEU LEU SEQRES 23 A 291 GLU VAL ARG SER TRP SEQRES 1 B 291 MET MET LEU SER LEU ASN ASN LEU GLN ASN ILE ILE TYR SEQRES 2 B 291 ASN PRO VAL ILE PRO PHE VAL GLY THR ILE PRO ASP GLN SEQRES 3 B 291 LEU ASP PRO GLY THR LEU ILE VAL ILE ARG GLY HIS VAL SEQRES 4 B 291 PRO SER ASP ALA ASP ARG PHE GLN VAL ASP LEU GLN ASN SEQRES 5 B 291 GLY SER SER MET LYS PRO ARG ALA ASP VAL ALA PHE HIS SEQRES 6 B 291 PHE ASN PRO ARG PHE LYS ARG ALA GLY CYS ILE VAL CYS SEQRES 7 B 291 ASN THR LEU ILE ASN GLU LYS TRP GLY ARG GLU GLU ILE SEQRES 8 B 291 THR TYR ASP THR PRO PHE LYS ARG GLU LYS SER PHE GLU SEQRES 9 B 291 ILE VAL ILE MET VAL LEU LYS ASP LYS PHE GLN VAL ALA SEQRES 10 B 291 VAL ASN GLY LYS HIS THR LEU LEU TYR GLY HIS ARG ILE SEQRES 11 B 291 GLY PRO GLU LYS ILE ASP THR LEU GLY ILE TYR GLY LYS SEQRES 12 B 291 VAL ASN ILE HIS SER ILE GLY PHE SER PHE SER SER HIS SEQRES 13 B 291 MET ARG LEU PRO PHE ALA ALA ARG LEU ASN THR PRO MET SEQRES 14 B 291 GLY PRO GLY ARG THR VAL VAL VAL LYS GLY GLU VAL ASN SEQRES 15 B 291 ALA ASN ALA LYS SER PHE ASN VAL ASP LEU LEU ALA GLY SEQRES 16 B 291 LYS SER LYS ASP ILE ALA LEU HIS LEU ASN PRO ARG LEU SEQRES 17 B 291 ASN ILE LYS ALA PHE VAL ARG ASN SER PHE LEU GLN GLU SEQRES 18 B 291 SER TRP GLY GLU GLU GLU ARG ASN ILE THR SER PHE PRO SEQRES 19 B 291 PHE SER PRO GLY MET TYR PHE GLU MET ILE ILE TYR CYS SEQRES 20 B 291 ASP VAL ARG GLU PHE LYS VAL ALA VAL ASN GLY VAL HIS SEQRES 21 B 291 SER LEU GLU TYR LYS HIS ARG PHE LYS GLU LEU SER SER SEQRES 22 B 291 ILE ASP THR LEU GLU ILE ASN GLY ASP ILE HIS LEU LEU SEQRES 23 B 291 GLU VAL ARG SER TRP HET BGC C 1 12 HET GAL C 2 11 HET SIA C 3 20 HET BGC D 1 12 HET GAL D 2 11 HET BGC E 1 12 HET GAL E 2 11 HET SIA E 3 20 HET BGC F 1 12 HET GAL F 2 11 HET EDO A 406 4 HET EDO A 407 4 HET EDO A 408 4 HET EDO A 409 4 HET EDO A 410 4 HET EDO A 411 4 HET EDO A 412 4 HET EDO A 413 4 HET EDO A 414 4 HET EDO A 415 4 HET EDO A 416 4 HET EDO B 406 4 HET EDO B 407 4 HET EDO B 408 4 HET EDO B 409 4 HET EDO B 410 4 HET EDO B 411 4 HET EDO B 412 4 HET EDO B 413 4 HET EDO B 414 4 HET EDO B 415 4 HET EDO B 416 4 HET EDO B 417 4 HET EDO B 418 4 HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM SIA N-ACETYL-ALPHA-NEURAMINIC ACID HETNAM EDO 1,2-ETHANEDIOL HETSYN BGC BETA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN SIA N-ACETYLNEURAMINIC ACID; SIALIC ACID; ALPHA-SIALIC HETSYN 2 SIA ACID; O-SIALIC ACID HETSYN EDO ETHYLENE GLYCOL FORMUL 3 BGC 4(C6 H12 O6) FORMUL 3 GAL 4(C6 H12 O6) FORMUL 3 SIA 2(C11 H19 N O9) FORMUL 7 EDO 24(C2 H6 O2) FORMUL 31 HOH *146(H2 O) HELIX 1 1 PRO A 132 ILE A 135 1 4 HELIX 2 1 LEU A 297 ILE A 300 1 4 HELIX 3 3 PRO B 132 ILE B 135 1 4 HELIX 4 4 LEU B 297 ILE B 300 1 4 SHEET 1 A 6 ILE A 11 ASN A 14 0 SHEET 2 A 6 ASN A 145 SER A 152 -1 N ILE A 149 O ILE A 12 SHEET 3 A 6 GLY A 30 VAL A 39 -1 N VAL A 34 O GLY A 150 SHEET 4 A 6 LYS A 101 LEU A 110 -1 N ILE A 105 O ILE A 35 SHEET 5 A 6 LYS A 113 VAL A 118 -1 N GLN A 115 O MET A 108 SHEET 6 A 6 LYS A 121 GLY A 127 -1 N TYR A 126 O PHE A 114 SHEET 1 B 6 PHE A 19 ILE A 23 0 SHEET 2 B 6 ASP A 136 GLY A 142 -1 N LEU A 138 O GLY A 21 SHEET 3 B 6 ASP A 44 GLN A 51 -1 N GLN A 47 O TYR A 141 SHEET 4 B 6 ASP A 61 PHE A 70 -1 N VAL A 62 O LEU A 50 SHEET 5 B 6 CYS A 75 ILE A 82 -1 N LEU A 81 O VAL A 62 SHEET 6 B 6 LYS A 85 GLY A 87 -1 O LYS A 85 N ILE A 82 SHEET 1 C 6 PHE A 19 ILE A 23 0 SHEET 2 C 6 ASP A 136 GLY A 142 -1 N LEU A 138 O GLY A 21 SHEET 3 C 6 ASP A 44 GLN A 51 -1 N GLN A 47 O TYR A 141 SHEET 4 C 6 ASP A 61 PHE A 70 -1 N VAL A 62 O LEU A 50 SHEET 5 C 6 CYS A 75 ILE A 82 -1 N LEU A 81 O VAL A 62 SHEET 6 C 6 GLU A 90 TYR A 93 -1 N THR A 92 O ILE A 76 SHEET 1 D 5 HIS A 310 TRP A 317 0 SHEET 2 D 5 GLY A 198 VAL A 207 -1 N LYS A 204 O GLU A 313 SHEET 3 D 5 MET A 265 ASP A 274 -1 N MET A 269 O LYS A 204 SHEET 4 D 5 GLU A 277 VAL A 282 -1 N LYS A 279 O TYR A 272 SHEET 5 D 5 VAL A 285 LYS A 291 -1 N SER A 287 O VAL A 280 SHEET 1 E 7 SER A 4 ASN A 6 0 SHEET 2 E 7 PHE A 187 ASN A 192 -1 N ASN A 192 O SER A 4 SHEET 3 E 7 ASP A 301 GLY A 307 -1 N LEU A 303 O ALA A 189 SHEET 4 E 7 LYS A 212 LEU A 219 -1 N ASN A 215 O ASN A 306 SHEET 5 E 7 ASP A 225 LEU A 234 -1 N ALA A 227 O LEU A 218 SHEET 6 E 7 ALA A 238 LEU A 245 -1 N PHE A 244 O ALA A 227 SHEET 7 E 7 SER A 248 GLY A 250 -1 N SER A 248 O LEU A 245 SHEET 1 F 7 SER A 4 ASN A 6 0 SHEET 2 F 7 PHE A 187 ASN A 192 -1 N ASN A 192 O SER A 4 SHEET 3 F 7 ASP A 301 GLY A 307 -1 N LEU A 303 O ALA A 189 SHEET 4 F 7 LYS A 212 LEU A 219 -1 N ASN A 215 O ASN A 306 SHEET 5 F 7 ASP A 225 LEU A 234 -1 N ALA A 227 O LEU A 218 SHEET 6 F 7 ALA A 238 LEU A 245 -1 N PHE A 244 O ALA A 227 SHEET 7 F 7 GLU A 252 ASN A 255 -1 N GLU A 253 O ARG A 241 SHEET 1 G 6 ILE B 11 ASN B 14 0 SHEET 2 G 6 ASN B 145 SER B 152 -1 N ILE B 149 O ILE B 12 SHEET 3 G 6 GLY B 30 VAL B 39 -1 N VAL B 34 O GLY B 150 SHEET 4 G 6 LYS B 101 LEU B 110 -1 N ILE B 105 O ILE B 35 SHEET 5 G 6 LYS B 113 VAL B 118 -1 N GLN B 115 O MET B 108 SHEET 6 G 6 LYS B 121 GLY B 127 -1 N TYR B 126 O PHE B 114 SHEET 1 H 6 PHE B 19 ILE B 23 0 SHEET 2 H 6 ASP B 136 GLY B 142 -1 N LEU B 138 O GLY B 21 SHEET 3 H 6 ASP B 44 GLN B 51 -1 N GLN B 47 O TYR B 141 SHEET 4 H 6 ASP B 61 PHE B 70 -1 N VAL B 62 O LEU B 50 SHEET 5 H 6 CYS B 75 ILE B 82 -1 N LEU B 81 O VAL B 62 SHEET 6 H 6 LYS B 85 GLY B 87 -1 O LYS B 85 N ILE B 82 SHEET 1 I 6 PHE B 19 ILE B 23 0 SHEET 2 I 6 ASP B 136 GLY B 142 -1 N LEU B 138 O GLY B 21 SHEET 3 I 6 ASP B 44 GLN B 51 -1 N GLN B 47 O TYR B 141 SHEET 4 I 6 ASP B 61 PHE B 70 -1 N VAL B 62 O LEU B 50 SHEET 5 I 6 CYS B 75 ILE B 82 -1 N LEU B 81 O VAL B 62 SHEET 6 I 6 GLU B 90 TYR B 93 -1 N THR B 92 O ILE B 76 SHEET 1 J 5 HIS B 310 TRP B 317 0 SHEET 2 J 5 GLY B 198 VAL B 207 -1 N LYS B 204 O GLU B 313 SHEET 3 J 5 MET B 265 ASP B 274 -1 N MET B 269 O LYS B 204 SHEET 4 J 5 GLU B 277 VAL B 282 -1 N LYS B 279 O TYR B 272 SHEET 5 J 5 VAL B 285 LYS B 291 -1 N SER B 287 O VAL B 280 SHEET 1 K 7 SER B 4 ASN B 6 0 SHEET 2 K 7 PHE B 187 ASN B 192 -1 N ASN B 192 O SER B 4 SHEET 3 K 7 ASP B 301 GLY B 307 -1 N LEU B 303 O ALA B 189 SHEET 4 K 7 LYS B 212 LEU B 219 -1 N ASN B 215 O ASN B 306 SHEET 5 K 7 ASP B 225 LEU B 234 -1 N ALA B 227 O LEU B 218 SHEET 6 K 7 ALA B 238 LEU B 245 -1 N PHE B 244 O ALA B 227 SHEET 7 K 7 SER B 248 GLY B 250 -1 N SER B 248 O LEU B 245 SHEET 1 L 7 SER B 4 ASN B 6 0 SHEET 2 L 7 PHE B 187 ASN B 192 -1 N ASN B 192 O SER B 4 SHEET 3 L 7 ASP B 301 GLY B 307 -1 N LEU B 303 O ALA B 189 SHEET 4 L 7 LYS B 212 LEU B 219 -1 N ASN B 215 O ASN B 306 SHEET 5 L 7 ASP B 225 LEU B 234 -1 N ALA B 227 O LEU B 218 SHEET 6 L 7 ALA B 238 LEU B 245 -1 N PHE B 244 O ALA B 227 SHEET 7 L 7 GLU B 252 ASN B 255 -1 N GLU B 253 O ARG B 241 LINK O4 BGC C 1 C1 GAL C 2 1555 1555 1.39 LINK O3 GAL C 2 C2 SIA C 3 1555 1555 1.39 LINK O4 BGC D 1 C1 GAL D 2 1555 1555 1.39 LINK O4 BGC E 1 C1 GAL E 2 1555 1555 1.39 LINK O3 GAL E 2 C2 SIA E 3 1555 1555 1.39 LINK O4 BGC F 1 C1 GAL F 2 1555 1555 1.38 CISPEP 1 ILE A 17 PRO A 18 0 0.45 CISPEP 2 LYS A 57 PRO A 58 0 0.07 CISPEP 3 LEU A 185 PRO A 186 0 0.03 CISPEP 4 ILE B 17 PRO B 18 0 0.92 CISPEP 5 LYS B 57 PRO B 58 0 -0.04 CISPEP 6 LEU B 185 PRO B 186 0 -0.04 CRYST1 74.133 80.713 129.296 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013489 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012390 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007734 0.00000